Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-005043
Filing Date
2021-01-28
Accepted
2021-01-28 19:45:34
Documents
1
Period of Report
2021-01-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3787
  Complete submission text file 0001213900-21-005043.txt   5362
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Stilley William B. III (Reporting) CIK: 0001718069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38323 | Film No.: 21567357